Enhanced long-term dietary change and adherence in a nutrigenomics-guided lifestyle intervention compared to a population-based (GLB/DPP) lifestyle intervention for weight management: results from the NOW randomised controlled trial

Justine Horne, Jason Gilliland, Colleen O'Connor, Jamie Seabrook, Janet Madill, Justine Horne, Jason Gilliland, Colleen O'Connor, Jamie Seabrook, Janet Madill

Abstract

Background: Adherence to nutritional guidelines for chronic disease prevention and management remains a challenge in clinical practice. Innovative strategies are needed to help optimise dietary behaviour change.

Objective: The objective of this study was to determine if a nutrigenomics-guided lifestyle intervention programme could be used to motivate greater dietary adherence and change in dietary intake short-term, moderate-term and long-term compared to the gold-standard population-based weight management intervention (Group Lifestyle Balance (GLB)/Diabetes Prevention Programme (DPP)).

Design: The Nutrigenomics, Overweight/Obesity, and Weight Management (NOW) randomised controlled trial is a pragmatic, parallel-group, superiority clinical trial (n=140), which was conducted at the East Elgin Family Health Team (EEFHT). GLB weight management groups were prerandomised 1:1 to receive either the standard GLB programme or a modified GLB+nutrigenomics (GLB+NGx) programme. Three 24-hour recalls were collected at baseline, 3, 6 and 12 months using the validated multiple pass method. Research assistants collecting the three 24-hour recalls were blinded to the participants' group assignments. Statistical analyses included split plot analyses of variance (ANOVAs), two-way ANOVAs, binary logistic regression, χ2 and Fisher's exact tests. Using the Theory of Planned Behaviour as guidance, key confounding factors of behaviour change were considered in the analyses. This study was registered with clinicaltrials.gov (NCT03015012).

Results: Only the GLB+NGx group significantly reduced their total fat intake from baseline to 12-month follow-up (from 36.0%±4.8% kcal to 30.2%±8.7% kcal, p=0.02). Long-term dietary adherence to total fat and saturated fat guidelines was also significantly (p<0.05) greater in the GLB+NGx group compared to the standard GLB group.

Conclusions: Weight management interventions guided by nutrigenomics can motivate long-term improvements in dietary fat intake above and beyond gold-standard population-based interventions.

Keywords: nutrition assessment; precision nutrition; weight management.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Flow diagram of participants from baseline to 3-month, 6-month and 12 month follow-up. GLB, Group Lifestyle Balance; NGx, nutrigenomics.
Figure 2
Figure 2
Change in percent of calories from total fat. Significant reduction in total fat intake in the GLB+NGx group only (repeated-measures analysis of variance: p=0.02). GLB, Group Lifestyle Balance; NGx, nutrigenomics.

References

    1. Subbiah MTR. Understanding the nutrigenomic definitions and concepts at the food-genome junction. OMICS 2008;12:229–35. 10.1089/omi.2008.0033
    1. Vallée Marcotte B, Cormier H, Garneau V, et al. . Nutrigenetic testing for personalized nutrition: an evaluation of public perceptions, attitudes, and concerns in a population of French Canadians. Lifestyle Genom 2018;11:155–62. 10.1159/000499626
    1. Nielsen DE, Shih S, El-Sohemy A. Perceptions of genetic testing for personalized nutrition: a randomized trial of DNA-based dietary advice. J Nutrigenet Nutrigenomics 2014;7:94–104. 10.1159/000365508
    1. Cormier H, Tremblay BL, Paradis A-M, et al. . Nutrigenomics - perspectives from registered dietitians: a report from the Quebec-wide e-consultation on nutrigenomics among registered dietitians. J Hum Nutr Diet 2014;27:391–400. 10.1111/jhn.12194
    1. Saukko P. State of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation. Proc Nutr Soc 2013;72:53–60. 10.1017/S0029665112002960
    1. Drabsch T, Holzapfel C. A scientific perspective of personalised gene-based dietary recommendations for weight management. Nutrients 2019;11:617–14. 10.3390/nu11030617
    1. Morin K. Knowledge and attitudes of Canadian consumers and health care professionals regarding nutritional genomics. OMICS 2009;13:37–41. 10.1089/omi.2008.0047
    1. Horne J, Madill J, O'Connor C, et al. . A systematic review of genetic testing and lifestyle behaviour change: are we using high-quality genetic interventions and considering behaviour change theory? Lifestyle Genom 2018;11:49–63. 10.1159/000488086
    1. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991;50:179–211. 10.1016/0749-5978(91)90020-T
    1. Horne J, Madill J, Gilliland J. Incorporating the 'Theory of Planned Behavior' into personalized healthcare behavior change research: a call to action. Per Med 2017;14:521–9. 10.2217/pme-2017-0038
    1. Meisel SF, Beeken RJ, van Jaarsveld CHM, et al. . Genetic susceptibility testing and readiness to control weight: results from a randomized controlled trial. Obesity 2015;23:305–12. 10.1002/oby.20958
    1. Rief W, Conradt M, Dierk J-M, et al. . Is information on genetic determinants of obesity helpful or harmful for obese people?--A randomized clinical trial. J Gen Intern Med 2007;22:1553–9. 10.1007/s11606-007-0353-7
    1. Knowler WC, Barrett-Connor E, Fowler SE, et al. . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403. 10.1056/NEJMoa012512
    1. McTigue KM, Conroy MB, Bigi L, et al. . Weight loss through living well: translating an effective lifestyle intervention into clinical practice. Diabetes Educ 2009;35:199–208. 10.1177/0145721709332815
    1. Piatt GA, Seidel MC, Chen H-Y, et al. . Two-Year results of translating the diabetes prevention program into an urban, underserved community. Diabetes Educ 2012;38:798–804. 10.1177/0145721712458834
    1. Xiao L, Yank V, Wilson SR, et al. . Two-Year weight-loss maintenance in primary care-based diabetes prevention program lifestyle interventions. Nutr Diabetes 2013;3:e76–9. 10.1038/nutd.2013.17
    1. Horne J, Gilliland J, O’Connor C, et al. . Study protocol of a pragmatic randomized controlled trial incorporated into the group lifestyle Balance™ program: the nutrigenomics, overweight/obesity and weight management trial (the now trial). BMC Public Health 2019;19:1–10. 10.1186/s12889-019-6621-8
    1. Dallal G. , 2017. Available:
    1. Canada H. Dietary reference intakes, 2010. Available: [Accessed 4 Nov 2019].
    1. University of Pittsburgh Dpp group lifestyle balance curriculum, 2020.
    1. Jenkins NDM, Colquhoun RJ, Tomko PM, et al. . Genetic variant in the β2 -adrenergic receptor (Arg16Gly) influences fat-free mass, muscle strength and motor unit behaviour in young men. Exp Physiol 2018;103:1645–55. 10.1113/EP087145
    1. Josse AR, Da Costa LA, Campos H, et al. . Associations between polymorphisms in the AhR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption. Am J Clin Nutr 2012;96:665–71. 10.3945/ajcn.112.038794
    1. Banks NF, Tomko PM, Colquhoun RJ, et al. . Genetic Polymorphisms in ADORA2A and CYP1A2 Influence Caffeine’s Effect on Postprandial Glycaemia. Sci Rep 2019;9:1–9. 10.1038/s41598-019-46931-0
    1. Madill J. Nutrigenomics, Overweight/Obesity and Weight Management Trial (NOW Trial), 2016. Available: [Accessed 29 Oct 2019].
    1. Conway JM, Ingwersen LA, Vinyard BT, et al. . Effectiveness of the US department of agriculture 5-step multiple-pass method in assessing food intake in obese and nonobese women. Am J Clin Nutr 2003;77:1171–8. 10.1093/ajcn/77.5.1171
    1. Ontario Ministry of Health and Long-Term Care Schedule M program description: primary care diabetes prevention program 2017-2018, 2018.
    1. Mayer-Davis EJ, Sparks KC, Hirst K, et al. . Dietary intake in the diabetes prevention program cohort: baseline and 1-year post randomization. Ann Epidemiol 2004;14:763–72. 10.1016/j.annepidem.2004.02.004
    1. Popova L. The extended parallel process model: illuminating the gaps in research. Health Educ Behav 2012;39:455–73. 10.1177/1090198111418108
    1. Rankin A, Bunting BP, Poínhos R, et al. . Food choice motives, attitude towards and intention to adopt personalised nutrition. Public Health Nutr 2018;21:2606–16. 10.1017/S1368980018001234
    1. Appleton KM. Barriers to and facilitators of the consumption of animal-based protein-rich foods in older adults. Nutrients 2016;8:187. 10.3390/nu8040187
    1. Best RL, Appleton KM. The consumption of protein-rich foods in older adults: an exploratory focus group study. J Nutr Educ Behav 2013;45:751–5. 10.1016/j.jneb.2013.03.008
    1. Hietaranta-Luoma H-L, Tahvonen R, Iso-Touru T, et al. . An intervention study of individual, apoE genotype-based dietary and physical-activity advice: impact on health behavior. J Nutrigenet Nutrigenomics 2014;7:161–74. 10.1159/000371743
    1. Nielsen DE, El-Sohemy A. Disclosure of genetic information and change in dietary intake: a randomized controlled trial. PLoS One 2014;9:e112665. 10.1371/journal.pone.0112665
    1. Chao S, Roberts JS, Marteau TM, et al. . Health behavior changes after genetic risk assessment for Alzheimer disease: the reveal study. Alzheimer Dis Assoc Disord 2008;22:94–7. 10.1097/WAD.0b013e31815a9dcc
    1. Shim J-S, Oh K, Kim HC. Dietary assessment methods in epidemiologic studies. Epidemiol Health 2014;36:e2014009. 10.4178/epih/e2014009
    1. Corella D, et al. APOA2, dietary fat, and body mass index. Arch Intern Med 2009;169:1897–906. 10.1001/archinternmed.2009.343
    1. Anderson TJ, Grégoire J, Pearson GJ, et al. . 2016 Canadian cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 2016;32:1263–82. 10.1016/j.cjca.2016.07.510

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する